[ Price : $8.95]
Again balking at efforts to induce transparency, FDA maintains silence on charges that it has stacked next weeks public advisory p...[ Price : $8.95]
Federal Register Notice: FDA is denying a request by Delmont Labs for a hearing on a proposal to revoke the companys license based...[ Price : $8.95]
Sequella files an IND with FDA to test SQ109 in patients with H. pylori-related duodenal ulcers.[ Price : $8.95]
FDA accepts for review a Bristol-Myers Squibb supplemental BLA for a subcutaneous formulation of Orencia (abatacept).[ Price : $8.95]
Cubist Pharmaceuticals petitions FDA to block approval of generic Cubicin (daptomycin) until potential ANDA submissions meet certa...[ Price : $8.95]
FDA's Gastroenterology and Urology Devices Panel votes to recommend wider use for Allergan's LAP-Band System for weight reduction ...[ Price : $8.95]
In a new Columbia Journalism Review article, FDA Webview editor Jim Dickinson tells how government press officers stole our freedo...[ Price : $8.95]
Vivus says it is planning a second quarter 2011 NDA submission for its erectile dysfunction drug TA-314 (avanafil) after reporting...